US regulators revoked emergency authorization for
Janssen informed the
“FDA has determined that it is appropriate to protect the public health or safety to revoke this authorization,” according to the statement. The company “does not intend to update the strain composition of this vaccine to address emerging variants.”
J&J’s single-dose vaccine faced problems early ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.